Article Versions Notes

Feldman F, Koudoufio M, El-Jalbout R, Sauvé MF, Ahmarani L, Sané AT, Ould-Chikh N-E-H, N’Timbane T, Patey N, Desjardins Y, et al. Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders. Antioxidants. 2023; 12(1):90. https://doi.org/10.3390/antiox12010090

Feldman, Francis, Mireille Koudoufio, Ramy El-Jalbout, Mathilde Foisy Sauvé, Lena Ahmarani, Alain Théophile Sané, Nour-El-Houda Ould-Chikh, Thierry N’Timbane, Natalie Patey, Yves Desjardins, and et al. 2023. "Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders" Antioxidants 12, no. 1: 90. https://doi.org/10.3390/antiox12010090

Feldman, F., Koudoufio, M., El-Jalbout, R., Sauvé, M. F., Ahmarani, L., Sané, A. T., Ould-Chikh, N.-E.-H., N’Timbane, T., Patey, N., Desjardins, Y., Stintzi, A., Spahis, S., & Levy, E. (2023). Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders. Antioxidants, 12(1), 90. https://doi.org/10.3390/antiox12010090